pancreatitis from glp-1 Risk Associated with Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis Risk for Acute Pancreatitis from

When an FDA investigator finds that zero out of 23 investigations followed the firms own SOP, it demonstrates not just a failure of execution but a failure of management oversight

GHK-Cu is not FDA-approved for any indication

Czstym zjawiskiem jest to, i pacjent stosuje kilka lekw NLPZ bez odpowiedniej wiedzy o skutkach takiego postpowania i bez konsultacji lekarskiej, co ogranicza kontrol nad bezpieczestwem ich stosowania

International Journal of Endocrinology, 2018

A normal lab panel does not prove growth-pathway exposure is risk-free

They learned that the ingredient cost to manufacture a one-month supply of the products was so low (one study estimated less than $5 for semaglutide products) that they could manufacture and sell to cash-paying patients for $100 to $300 and still earn a significant profit